917
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS

&
Pages 783-785 | Received 03 Aug 2023, Accepted 22 Sep 2023, Published online: 27 Sep 2023
 

Declaration of interests

S Vuvic and MC Kiernan are directors of companies that hold equity in Clene Nanomedicine. S Vuvic, MC Kiernan, and their respective institutions receive research funding support for the Rescue-ALS study from Clene Nanomedicine. MC Kiernan was Editor-in-Chief of the Journal of Neurology, Neurosurgery and Psychiatry (BMJ Publishers, UK).

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.